Risankizumab vs Ustekinumab for Moderate to Severe Plaque Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Risankizumab Versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis
N. Engl. J. Med 2017 Apr 20;376(16)1551-1560, KA Papp, A Blauvelt, M Bukhalo, M Gooderham, JG Krueger, JP Lacour, A Menter, S Philipp, H Sofen, S Tyring, BR Berner, S Visvanathan, C Pamulapati, N Bennett, M Flack, P Scholl, SJ PadulaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.